
Imediab MP 1 Tablet SR
Marketer
Pfizer Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Imediab MP 1 Tablet SR
Glimepiride and Metformin extended-release tablets are a dual-action medication designed to manage blood glucose levels. This treatment, used in conjunction with a balanced diet and regular physical activity, enhances glycemic control in adults diagnosed with type 2 diabetes. It facilitates improved insulin utilization, resulting in reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food is recommended to minimize gastrointestinal discomfort. Should you miss a dose, take it promptly; however, if your next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. Excessive intake may trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping elevates the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common adverse effects include nausea, diarrhea, abdominal pain, headache, increased risk of bone fracture, and respiratory infections. Prior to initiating therapy, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function assessment will be conducted before treatment commencement. Limit alcohol consumption to mitigate the potential for increased side effects.
Primary Ingredients of Imediab MP 1 Tablet SR
No text was provided to rewrite. Please provide the text you wish to be rephrased.
Uses of Imediab MP 1 Tablet SR
Managing Type 2 diabetes
Major Benefits of Imediab MP 1 Tablet SR:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Imediab MP 1 Tablet SR with a meal.
Common Side effects of Imediab MP 1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Imediab MP 1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Imediab MP 1 Tablet SR with a meal.
How Imediab MP 1 Tablet SR works:
Imediab MP1 SR tablets contain a triple-action formulation of glimepiride, metformin, and pioglitazone to manage blood sugar levels. These medications employ distinct methods to improve glycemic control when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Imediab MP 1 Tablet SR is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Imediab MP 1 Tablet SR during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before taking it.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Imediab MP 1 Tablet likely poses a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk, potentially harming the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Imediab MP 1 Tablet SR to individuals with kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Avoid using Imediab MP 1 Tablet SR in patients exhibiting severe kidney dysfunction. Consistent monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Imediab MP 1 Tablet SR; dosage modification may be necessary. Consult a physician before use. Imediab MP 1 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Imediab MP 1 Tablet SR :
Should you forget to take a dose of Imediab MP 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Imediab MP 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
